SCHEMBL5164205

SCHEMBL5164205

Nc1ccc(O)cc1CC(=O)NCC(O)CO

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 1/20 0.34
EGFR P00533 5/20 0.33
CA2 P00918 1/20 0.33
ESR2 Q92731 2/20 0.32
ESR1 P03372 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
NPY1R P25929 1/20 0.32
PTGS2 P35354 1/20 0.32
OPRD1 P41143 1/20 0.32
MTOR P42345 1/20 0.32
HK2 P52789 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32
THPO P40225 1/20 0.32
HSD17B10 Q99714 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5163215 0.82 HSP90AA1 (0.37) MEN1KMT2AHPGDEGFRCYP2C9
SCHEMBL5164514 0.80 CNR2 (0.39) MEN1KMT2AKDM4EALDH1A1EGFR
SCHEMBL5162938 0.79 HPGD (0.34) KDM4EALDH1A1HPGDEGFRCA2
SCHEMBL5162190 0.78 MEN1 (0.40) MEN1KMT2AHPGDEGFRPTGS2
SCHEMBL5434603 0.78 GAA (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5163737 0.77 PTGS2 (0.42) MEN1KMT2AHPGDEGFRCA2
SCHEMBL5160286 0.77 PDK2 (0.38) MEN1KMT2AEGFRCA2PMP22
SCHEMBL5161617 0.75 TSHR (0.41) KMT2AKDM4EALDH1A1HPGDEGFR
SCHEMBL5162506 0.74 CTSS (0.37) MEN1KMT2AALDH1A1EGFRPOLB
SCHEMBL5162641 0.74 ALDH1A1 (0.51) MEN1KMT2AALDH1A1HPGDCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US claimed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP claimed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO claimed
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds PROCTER & GAMBLE COMPANY, THE 2007-03-29 US disclosed
EP-1762218-A1 4-aminophenol derivatives and colorants comprising these compounds Wella Aktiengesellschaft (DE) 2007-03-14 EP disclosed
WO-2007026313-A2 4-AMINOPHENOL DERIVATIVES AND COLORANTS COMPRISING THESE COMPOUNDS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070067922-A1 4-Aminophenol derivatives and colorants comprising these compounds KRT18, S100A4, CKAP4 MEN1 4874/4885KMT2A 1287/4885KDM4E 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.